Annual Debt To Equity
0.03
0.000.00%
December 31, 2023
Summary
- As of February 7, 2025, PCSA annual debt to equity ratio is 0.03, unchanged on December 31, 2023.
- During the last 3 years, PCSA annual debt to equity has risen by +0.02 (+200.00%).
- PCSA annual debt to equity is now -99.54% below its all-time high of 6.56, reached on December 31, 2017.
Performance
PCSA Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
0.03
+0.01+50.00%
September 30, 2024
Summary
- As of February 7, 2025, PCSA quarterly debt to equity ratio is 0.03, with the most recent change of +0.01 (+50.00%) on September 30, 2024.
- Over the past year, PCSA quarterly debt to equity has increased by +0.01 (+50.00%).
- PCSA quarterly debt to equity is now -99.54% below its all-time high of 6.56, reached on December 31, 2017.
Performance
PCSA Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
PCSA Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | +50.0% |
| 3 y3 years | +200.0% | 0.0% |
| 5 y5 years | +50.0% | 0.0% |
PCSA Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | at high | -100.0% |
| 5 y | 5-year | -76.9% | -100.0% | -90.6% | -100.0% |
| alltime | all time | -99.5% | +104.3% | -99.5% | +100.1% |
Processa Pharmaceuticals Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 0.03(+50.0%) |
| Jun 2024 | - | 0.02(0.0%) |
| Mar 2024 | - | 0.02(-33.3%) |
| Dec 2023 | 0.03(0.0%) | 0.03(+50.0%) |
| Sep 2023 | - | 0.02(0.0%) |
| Jun 2023 | - | 0.02(0.0%) |
| Mar 2023 | - | 0.02(-33.3%) |
| Dec 2022 | 0.03(>+9900.0%) | 0.03(+200.0%) |
| Sep 2022 | - | 0.01(>+9900.0%) |
| Jun 2022 | - | 0.00(0.0%) |
| Mar 2022 | - | 0.00(0.0%) |
| Dec 2021 | 0.00(-100.0%) | 0.00(0.0%) |
| Sep 2021 | - | 0.00(0.0%) |
| Jun 2021 | - | 0.00(-100.0%) |
| Mar 2021 | - | 0.01(0.0%) |
| Dec 2020 | 0.01(-92.3%) | 0.01(-96.9%) |
| Sep 2020 | - | 0.32(+28.0%) |
| Jun 2020 | - | 0.25(+78.6%) |
| Mar 2020 | - | 0.14(+7.7%) |
| Dec 2019 | 0.13(+550.0%) | 0.13(+333.3%) |
| Sep 2019 | - | 0.03(-50.0%) |
| Jun 2019 | - | 0.06(0.0%) |
| Mar 2019 | - | 0.06(+200.0%) |
| Dec 2018 | 0.02 | 0.02(0.0%) |
| Sep 2018 | - | 0.02(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | 0.02(-94.1%) |
| Mar 2018 | - | 0.34(-94.8%) |
| Dec 2017 | 6.56(-1050.7%) | 6.56(>+9900.0%) |
| Sep 2017 | - | 0.00(-100.0%) |
| Jun 2017 | - | -0.68(+3.0%) |
| Mar 2017 | - | -0.66(-4.3%) |
| Dec 2016 | -0.69(0.0%) | -0.69(-4.2%) |
| Sep 2016 | - | -0.72(-2.7%) |
| Jun 2016 | - | -0.74(+13.8%) |
| Mar 2016 | - | -0.65(-5.8%) |
| Dec 2015 | -0.69(-246.8%) | -0.69(-32.4%) |
| Sep 2015 | - | -1.02(-20.3%) |
| Jun 2015 | - | -1.28(-163.7%) |
| Mar 2015 | - | 2.01(+327.7%) |
| Dec 2014 | 0.47(+2.2%) | 0.47(-102.2%) |
| Sep 2014 | - | -21.48(-806.6%) |
| Jun 2014 | - | 3.04(+91.2%) |
| Mar 2014 | - | 1.59(+245.7%) |
| Dec 2013 | 0.46(+4.5%) | 0.46(-8.0%) |
| Sep 2013 | - | 0.50(-76.1%) |
| Jun 2013 | - | 2.09(+221.5%) |
| Mar 2013 | - | 0.65(+47.7%) |
| Dec 2012 | 0.44(-51.1%) | 0.44(+18.9%) |
| Sep 2012 | - | 0.37 |
| Dec 2011 | 0.90 | - |
FAQ
- What is Processa Pharmaceuticals annual debt to equity ratio?
- What is the all time high annual debt to equity for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual debt to equity year-on-year change?
- What is Processa Pharmaceuticals quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly debt to equity year-on-year change?
What is Processa Pharmaceuticals annual debt to equity ratio?
The current annual debt to equity of PCSA is 0.03
What is the all time high annual debt to equity for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual debt to equity ratio is 6.56
What is Processa Pharmaceuticals annual debt to equity year-on-year change?
Over the past year, PCSA annual debt to equity ratio has changed by 0.00 (0.00%)
What is Processa Pharmaceuticals quarterly debt to equity ratio?
The current quarterly debt to equity of PCSA is 0.03
What is the all time high quarterly debt to equity for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly debt to equity ratio is 6.56
What is Processa Pharmaceuticals quarterly debt to equity year-on-year change?
Over the past year, PCSA quarterly debt to equity ratio has changed by +0.01 (+50.00%)